Intellia Therapeutics, Inc.
Overview
Intellia Therapeutics, Inc. is a leading biotechnology company specializing in the development of CRISPR/Cas9 gene-editing technology to create transformative medicines. The company is focused on developing innovative therapies for genetic diseases and cancer, aiming to provide patients with one-time, potentially curative treatments.
Therapeutic areas
Genetic DiseasesOncology
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Intellia Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.